The labeling updates address the risk of early-onset toxicity, including life-threatening adverse events in patients with DPD ...
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.
Cytokinetics, Incorporated remains a Buy following FDA approval of MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy (oHCM). MYQORZO‘s label offers subtle practical advantages over ...
(CNN) — Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to the product’s safety label to reflect research about a possible ...
MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...
Former FDA Commissioner Dr Scott Gottlieb said the change could allow companies to make disclaimers less noticeable, though it remains unclear how consumers would be affected. (HealthDay News) — The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has requested mention of risk for suicidal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results